Low-income, less educated don’t have same access to preventive treatments, researchers report By Robert Preidt THURSDAY, July 18 (HealthDay News) — Americans with low incomes and education levels are less likely to get eye care, a new study finds. Researchers examined data from nearly 3,600 people, aged 40 and older, who took part in the [Read More]
Category: Latest News
Gene Therapy Without Retinal Risk
Researchers have developed a method of delivering genes to the inner layers of the retina without the risks associated with injection into the delicate tissues themselves. This less invasive technique has been carried out successfully in animal models by a research team led by Drs. John G. Flannery and David V. Schaffer at the University [Read More]
Gene Expression in the Retina Expanded
Identifying the genetics of retinal degeneration has become especially important with progress of trials in gene therapy. Investigators have identified more than 200 retinal degeneration disease genes, but still haven’t been able to find the cause of disease in up to half of cases. Now Ocular Genomics Institute has announced that Drs. Michael Farkas, Eric [Read More]
Understand Drug Side Effects and Adverse Events
In the shadow of recent severe health problems caused by irresponsible repackaging (compounding) of drugs for use in the clinics, MD Support offers a free audio/visual presentation to help patients understand drug side effects and adverse events. Speaking to the International Low Vision Support Group, Dan Roberts addresses the compounding issue as part of a [Read More]
Clinical Trial Finds Antioxidants and Zinc Beneficial in Reducing Risk of Severe AMD
by Tom Hoglund, Information Officer Foundation Fighting Blindness October 2007 Reprinted by permission. (Updated May 6, 2013) Patients with advanced cases of dry age-related macular degeneration (AMD) can moderately lower the risk of developing the more severe wet form of the disease and preserve vision by taking a daily dose of antioxidant vitamins and zinc. [Read More]